John Muth

2.2k total citations
37 papers, 1.0k citations indexed

About

John Muth is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, John Muth has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in John Muth's work include CAR-T cell therapy research (15 papers), HIV, Drug Use, Sexual Risk (8 papers) and Acute Myeloid Leukemia Research (7 papers). John Muth is often cited by papers focused on CAR-T cell therapy research (15 papers), HIV, Drug Use, Sexual Risk (8 papers) and Acute Myeloid Leukemia Research (7 papers). John Muth collaborates with scholars based in United States, United Kingdom and Australia. John Muth's co-authors include John J. Potterat, Donald E. Woodhouse, Stephen Q. Muth, William W. Darrow, Alden S. Klovdahl, Richard Rothenberg, Richard B. Rothenberg, Helen Rogers, Jan Davidson‐Moncada and Paul A. Moore and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

John Muth

36 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Muth United States 12 453 409 335 205 192 37 1.0k
Kathleen Toomey United States 24 397 0.9× 427 1.0× 319 1.0× 131 0.6× 210 1.1× 98 1.7k
King K. Holmes United States 13 268 0.6× 588 1.4× 229 0.7× 81 0.4× 478 2.5× 16 1.0k
M. Kate Grabowski United States 23 257 0.6× 662 1.6× 810 2.4× 159 0.8× 59 0.3× 106 1.6k
Rachel Sacks‐Davis Australia 26 246 0.5× 1.2k 2.9× 374 1.1× 178 0.9× 19 0.1× 79 1.8k
Mohammed Kiddugavu Uganda 7 353 0.8× 576 1.4× 827 2.5× 181 0.9× 166 0.9× 9 1.2k
Mary P. Meehan Uganda 8 453 1.0× 782 1.9× 1.0k 3.1× 215 1.0× 246 1.3× 8 1.6k
Maria Xiridou Netherlands 16 162 0.4× 616 1.5× 345 1.0× 89 0.4× 108 0.6× 39 885
Daan Mulder Uganda 34 972 2.1× 1.2k 2.9× 1.7k 5.1× 370 1.8× 250 1.3× 52 3.5k
Emily Wong United States 16 77 0.2× 449 1.1× 503 1.5× 19 0.1× 59 0.3× 68 1.6k

Countries citing papers authored by John Muth

Since Specialization
Citations

This map shows the geographic impact of John Muth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Muth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Muth more than expected).

Fields of papers citing papers by John Muth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Muth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Muth. The network helps show where John Muth may publish in the future.

Co-authorship network of co-authors of John Muth

This figure shows the co-authorship network connecting the top 25 collaborators of John Muth. A scholar is included among the top collaborators of John Muth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Muth. John Muth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghobadi, Armin, Ibrahim Aldoss, Shannon L. Maude, et al.. (2024). Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL). Transplantation and Cellular Therapy. 30(2). S14–S15. 1 indexed citations
2.
Vadakekolathu, Jayakumar, Laura Arthur, Melissa Tran, et al.. (2024). W-NK1 Choreographs Innate and Adaptive Immune Responses to Provide a Robust and Durable Anti-AML Response. Blood. 144(Supplement 1). 916–916. 3 indexed citations
3.
Rutella, Sergio, Amanda F. Cashen, John Muth, et al.. (2023). S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML). HemaSphere. 7(S3). e4299744–e4299744. 1 indexed citations
4.
Rutella, Sergio, John Muth, Jayakumar Vadakekolathu, et al.. (2023). WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Intrinsically Overcomes Factors Restricting Adoptive Cell Therapy (ACT) in Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 466–466. 1 indexed citations
5.
Ghobadi, Armin, Ibrahim Aldoss, Shannon L. Maude, et al.. (2023). P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL). HemaSphere. 7(S3). e1789302–e1789302. 11 indexed citations
6.
Barwe, Sonali P., Anne Kisielewski, Ezio Bonvini, et al.. (2022). Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia. Journal of Clinical Medicine. 11(5). 1333–1333. 4 indexed citations
7.
Matei, Alexandru‐Emil, Andrea‐Hermina Györfi, Despina Soteriou, et al.. (2021). AB0420 CIRCULATING MONOCYTES HAVE DISTINCT PHYSICAL PROPERTIES THAT CORRELATE WITH DISEASE ACTIVITY AND SEVERITY AND PREDICT PROGRESSION IN SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases. 80. 1238–1238.
8.
Vadakekolathu, Jayakumar, Catherine Lai, Stephen Reeder, et al.. (2020). Abstract CT035: TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia. Cancer Research. 80(16_Supplement). CT035–CT035. 1 indexed citations
9.
Gopalakrishnapillai, Anilkumar, Anne Kisielewski, Ezio Bonvini, et al.. (2019). Effect of Ara-C on T-Cell Function and Flotetuzumab Activity in Pediatric Acute Myeloid Leukemia. Blood. 134(Supplement_1). 1387–1387. 1 indexed citations
10.
11.
Catenacci, Daniel V.T., Haeseong Park, Hope E. Uronis, et al.. (2018). Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).. Journal of Clinical Oncology. 36(15_suppl). 4030–4030. 12 indexed citations
12.
Rutella, Sergio, S. Church, Jayakumar Vadakekolathu, et al.. (2018). Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 × CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Blood. 132(Supplement 1). 444–444. 11 indexed citations
13.
14.
Potterat, John J., et al.. (2002). Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs. Sexually Transmitted Infections. 78(Supplement 1). i159–i163. 121 indexed citations
15.
Potterat, John J., Richard B. Rothenberg, John Muth, Donald E. Woodhouse, & Stephen Q. Muth. (1999). Invoking, Monitoring, and Relinquishing a Public Health Power. Sexually Transmitted Diseases. 26(6). 345–349. 3 indexed citations
16.
Woodhouse, Donald E., Richard B. Rothenberg, John J. Potterat, et al.. (1994). Mapping a social network of heterosexuals at high risk for HIV infection. AIDS. 8(9). 1331–1336. 108 indexed citations
17.
Klovdahl, Alden S., John J. Potterat, Donald E. Woodhouse, et al.. (1994). Social networks and infectious disease: The Colorado Springs study. Social Science & Medicine. 38(1). 79–88. 262 indexed citations
18.
Klovdahl, Alden S., et al.. (1992). HIV Infection in an Urban Social Network: a Progress Report. Bulletin of Sociological Methodology/Bulletin de Méthodologie Sociologique. 36(1). 24–33. 17 indexed citations
19.
Potterat, John J., et al.. (1990). Epidemiologic differences between chlamydia and gonorrhea.. American Journal of Public Health. 80(11). 1338–1342. 104 indexed citations
20.
Potterat, John J., et al.. (1989). Partner notification in the control of human immunodeficiency virus infection.. American Journal of Public Health. 79(7). 874–876. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Toomey Breakdown of academic impact, for papers by King K. Holmes Breakdown of academic impact, for papers by M. Kate Grabowski Breakdown of academic impact, for papers by Rachel Sacks‐Davis Breakdown of academic impact, for papers by Mohammed Kiddugavu Breakdown of academic impact, for papers by Mary P. Meehan Breakdown of academic impact, for papers by Maria Xiridou Breakdown of academic impact, for papers by Daan Mulder Breakdown of academic impact, for papers by Emily Wong
Rankless by CCL
2026